425: Atlantic Coastal Acquisition Corp. II Secures Non-Redemption Agreement with Investor for Abpro Business Combination

Sentiment:

Form 8-K


Atlantic Coastal Acquisition Corp. II entered into a non-redemption agreement with an investor to retain up to 124,352 shares, aiming to reduce redemptions in connection with its business combination with Abpro Corporation.

Summary

  • Atlantic Coastal Acquisition Corp. II (ACAB) has entered into a non-redemption agreement on November 5, 2024, with Sandia Investment Management LP, acting on behalf of certain investors, to reduce potential redemptions of ACAB's common stock.
  • The agreement pertains to a proposed business combination between ACAB and Abpro Corporation.
  • Investors agreed to rescind or reverse any previously submitted redemption demand for up to 124,352 shares of ACAB common stock.
  • Upon the deal's completion, ACAB will pay the investors an amount calculated as the number of shares multiplied by the redemption price, less the number of shares multiplied by $9.00.
  • ACAB had previously filed a registration statement on Form S-4 related to the business combination, including a proxy statement/prospectus.
  • The document also contains forward-looking statements and disclaimers regarding the uncertainty of the business combination's completion and potential risks.

Sentiment

Score: 7

Explanation: The document is cautiously optimistic. The non-redemption agreement is a positive step towards completing the business combination, but the document also acknowledges the inherent risks and uncertainties associated with forward-looking statements and the business combination itself.

Positives

  • The non-redemption agreement aims to secure investor commitment and reduce potential redemptions, increasing the likelihood of the business combination with Abpro being completed.
  • The agreement provides clarity on the terms of the non-redemption, including the payment structure for participating investors.
  • The Backstop Investor will only reverse or rescind redemption demands if the Backstop Investors Shares are able to be sold at a price higher than $9.00.

Negatives

  • The agreement involves a payment to investors who reverse their redemption demands, which could be seen as a cost associated with ensuring the business combination proceeds.
  • The deal is subject to various risks and uncertainties, including the possibility of termination and failure to obtain necessary approvals.

Risks

  • The business combination is subject to general economic, financial, legal, political, and business conditions.
  • Judicial proceedings involving Abpro could impact the deal.
  • Failure to obtain regulatory approvals or stockholder approval could prevent the completion of the transaction.
  • The amount of redemption requests made by ACAB's stockholders could affect the deal's viability.
  • The occurrence of events that may give rise to a right of one or both of ACAB and Abpro to terminate the Business Combination Agreement.
  • There are risks related to the rollout of Abpro’s business and the timing of expected business milestones.
  • Competition could affect Abpro's future business.

Future Outlook

The document includes forward-looking statements regarding the business combination with Abpro, including expectations for revenue, financial performance, and market opportunities; however, these statements are subject to risks and uncertainties, and actual results may differ materially.

Management Comments

  • ACAB and Abpro anticipate that subsequent events and developments will cause their assessments to change.
  • ACAB and Abpro specifically disclaim any obligation to update these forward-looking statements.

Industry Context

The announcement reflects the ongoing trend of SPACs seeking business combinations with private companies. The non-redemption agreement is a tactic used to ensure sufficient capital remains in the SPAC to fund the merged entity after the deal closes. The success of the merger will depend on Abpro's ability to execute its business plan and achieve its financial projections.

Comparison to Industry Standards

  • Non-redemption agreements are a common tool used in the SPAC industry to mitigate the risk of high redemption rates, which can jeopardize the funding of the target company.
  • Comparable SPAC transactions often involve similar agreements with investors to secure their commitment and reduce potential redemptions.
  • The specific terms of the agreement, such as the payment structure and the number of shares involved, are tailored to the specific circumstances of the deal and the SPAC's capital structure.

Stakeholder Impact

  • Shareholders: The agreement aims to increase the likelihood of the business combination being completed, which could impact the value of their investment.
  • Employees: The business combination could impact the future of employees at both ACAB and Abpro.
  • Customers: The business combination could impact the products and services offered by Abpro.
  • The Backstop Investor acknowledges that the Company has established a trust account (the Trust Account) containing the proceeds of its initial public offering (IPO) and certain proceeds of a private placement (including interest accrued from time to time thereon) for the benefit of its public shareholders and certain other parties (including the underwriters of the IPO).

Next Steps

  • ACAB will hold a special meeting of stockholders on November 7, 2024, to approve the proposed business combination.
  • The parties will work to satisfy the remaining conditions to closing and consummate the business combination.
  • ACAB will file a Current Report on Form 8-K with the SEC reporting the material terms of this Agreement.

Key Dates

DateDescription
December 11, 2023Date of the Business Combination Agreement between ACAB, Abpro Merger Sub, Inc., and Abpro Corporation.
June 30, 2024Date used for illustrative purposes to estimate the per share redemption price at approximately $11.22 based on the fair value of marketable securities held in the Trust Account.
October 18, 2024The Companys Registration Statement on Form S-4 (the Registration Statement) relating to the Business Combination went effective, and the Company filed the proxy statement/prospectus relating to the Business Combination.
November 5, 2024Date of the Non-Redemption Agreement between ACAB and Sandia Investment Management LP.
November 5, 2024Deadline to exercise the redemption rights of Common Stock of 5:00 p.m., Eastern Daylight time.
November 6, 2024Date of the report.
November 7, 2024Scheduled date for the special meeting of shareholders of the Company to approve the Business Combination.
November 20, 2024Termination date of the Non-Redemption Agreement if the Business Combination has not been consummated by such date.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.